Promega⁠(opens in a new window) is an established leader in life sciences, providing pioneering biological reagents and integrated systems used in research and applied technology. Their products, used by companies worldwide, have led to significant advancements in areas of therapeutic discovery, clinical research, and forensics.

Promega’s widespread integration of ChatGPT helps them deliver quality products faster to the biotech ecosystem—an effort that started from the top. “Innovation is something that is our lifeblood, and our future is based on developing solutions from the talent and ideas that our people have,” said Bill Linton, CEO of Promega. “AI works perfectly with this vision, helping people to see more of what they can do.”

Promega’s journey with OpenAI began when Poncho Meisenheimer, VP of Research and Development, introduced Linton to ChatGPT.

Linton immediately recognized its potential to help employees manage the company’s thousands of products and over 60,000 accounts: “I could envision our team co-creating with ChatGPT, using it as a coach, expert, or an extra set of hands to complete projects more efficiently,” he said.

Enthusiasm for ChatGPT spread with Linton’s buy-in, prompting the company to launch a pilot program to identify key use cases. Today, ChatGPT is an integral part of Promega’s workflows, with over 1,400 custom GPTs used by 80% of the company.

Promega's manufacturing operations are complex. With the manufacture of 4,000 products, readiness means constant planning in advance. This complexity is multiplied by customer needs for custom specifications.